{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:38:48Z","timestamp":1792607928852,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.pharep.2016.09.016","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T23:30:33Z","timestamp":1474500633000},"page":"150-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effect of intensive lipid-lowering therapies on cholinesterase activity in patients with coronary artery disease"],"prefix":"10.1007","volume":"69","author":[{"given":"Edyta","family":"Pytel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Bukowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Koter-Michalak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Olszewska-Banaszczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Gorzelak-Pabi\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena","family":"Broncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2016.09.016_bib0005","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ajh.2830260114","article-title":"Acetylcholinesterase in red blood cells","volume":"26","author":"Lawson","year":"1987","journal-title":"Am J Hematol"},{"key":"10.1016\/j.pharep.2016.09.016_bib0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"\u010colovi\u0107","year":"2013","journal-title":"Curr Neuropharm"},{"issue":"Suppl. A","key":"10.1016\/j.pharep.2016.09.016_bib0015","first-page":"11","article-title":"Acetylo- i butyrylcholinoesteraza\u2013budowa i funkcje ich inhibitory","volume":"30","author":"Bukowska","year":"2007","journal-title":"Curr Top Biophys"},{"key":"10.1016\/j.pharep.2016.09.016_bib0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12011-014-9948-0","article-title":"Protective effects of naringenin on iron-overload-induced cerebral cortex neurotoxicity correlated with oxidative stress","volume":"158","author":"Chtourou","year":"2014","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.pharep.2016.09.016_bib0025","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1124\/dmd.109.031724","article-title":"Identification of the human enzymes responsible for the enzymatic hydrolysis of aclidinium bromide","volume":"38","author":"Albert\u00ed","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.pharep.2016.09.016_bib0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/cs0850077","article-title":"Relationship between serum butyrylcholinesterase activity, hypertriglyceridaemia and insulin sensitivity in diabetes mellitus","volume":"85","author":"Abbott","year":"1993","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pharep.2016.09.016_bib0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00365510260296564","article-title":"Butyrylcholinesterase activity and risk factors for coronary artery disease","volume":"62","author":"Alcantara","year":"2002","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.pharep.2016.09.016_bib0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/0961203313518622","article-title":"Synergistic effects of BuChE non-UU phenotype and paraoxonase (PON1) 55M allele on the risk of systemic lupus erythematosus: influence on lipid and lipoprotein metabolism and oxidative stress, preliminary report","volume":"23","author":"Bahrehmand","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.pharep.2016.09.016_bib0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0009-8981(81)90106-6","article-title":"Serum pseudocholinesterase: high density lipoprotein cholesterol ratio as an index of risk for cardiovascular disease","volume":"115","author":"Kutty","year":"1981","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharep.2016.09.016_bib0050","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1373\/clinchem.2005.059857","article-title":"Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem","volume":"52","author":"Margalit","year":"2006","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.pharep.2016.09.016_bib0055","first-page":"253","article-title":"Acetylcholinesterase in the erythrocyte membrane","volume":"16","author":"Igisu","year":"1994","journal-title":"J Univ Occup Environ Health"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2016.09.016_bib0060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/08820139509062760","article-title":"Red but not dead: not a hapless sac of hemoglobin","volume":"24","author":"Greenwalt","year":"1995","journal-title":"Immunol Invest"},{"key":"10.1016\/j.pharep.2016.09.016_bib0065","first-page":"214","article-title":"The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis","volume":"17","author":"Brenner","year":"2003","journal-title":"Fed Am Soc Exp Biol J"},{"key":"10.1016\/j.pharep.2016.09.016_bib0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1432-1033.1980.tb04804.x","article-title":"Lipid\u2013protein interactions in human erythrocythe\u2013membrane acetylcholinesterase. Modula-tion of enzyme activity by lipids","volume":"109","author":"Frenkel","year":"1980","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pharep.2016.09.016_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2014.07.007","article-title":"Oxidized low density lipoprotein increases acetylcholinesterase activity correlating with reactive oxygen species production","volume":"78","author":"Yamchuen","year":"2014","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharep.2016.09.016_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/bcb-2015-0066","article-title":"Oxidative stress and damage to erythrocytes in patients with chronic obstructive pulmonary disease\u2014changes in ATPase and acetylcholinesterase activity","volume":"93","author":"Bukowska","year":"2015","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.pharep.2016.09.016_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/bcb-2013-0027","article-title":"Increased oxidative stress and decreased membrane fluidity in erythrocytes of CAD patients","volume":"91","author":"Pytel","year":"2013","journal-title":"Biochem Cell Biol"},{"issue":"11","key":"10.1016\/j.pharep.2016.09.016_bib0090","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s40265-015-0429-3","article-title":"Current treatment of dyslipidemia: evolving roles of non-statin and newer drugs","volume":"75","author":"Kones","year":"2015","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.pharep.2016.09.016_bib0095","doi-asserted-by":"crossref","first-page":"e001675","DOI":"10.1161\/JAHA.114.001675","article-title":"Effect of switching from statin monotherapy to ezetimibe\/simvastatin combination therapy compared with other intensified lipid-lowering strategies on lipoprotein subclasses in diabetic patients with symptomatic cardiovascular disease","volume":"4","author":"Le","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"10.1016\/j.pharep.2016.09.016_bib0100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11883-015-0550-5","article-title":"Role of ezetimibe in lipid-lowering and cardiovascular disease prevention","volume":"17","author":"Smith","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.pharep.2016.09.016_bib0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijcard.2015.08.103","article-title":"Safety and efficacy of ezetimibe: a meta-analysis","volume":"201","author":"Savarese","year":"2015","journal-title":"Int J Cardiol"},{"issue":"5","key":"10.1016\/j.pharep.2016.09.016_bib0110","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jacc.2015.05.064","article-title":"Ezetimibe and plaque regression: cholesterol lowering or pleiotropic effects?","volume":"66","author":"Crea","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharep.2016.09.016_bib0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2016.09.016_bib0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0167-4838(00)00218-1","article-title":"Comparison of salts effects on thereactions of acetylcholinesterase with cationic and anionic inhibitors","volume":"1544","author":"Tougu","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharep.2016.09.016_bib0125","first-page":"1","article-title":"Intensive statin therapy, used alone or in combination with ezetimibe, improves homocysteine level and lipid peroxidation to a similar degree in patients with coronary artery diseases","volume":"404","author":"Pytel","year":"2015","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2016.09.016_bib0130","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.lfs.2004.02.019","article-title":"Increased serum butyrylcholinesterase activity in type IIb hyperlipidaemic patients","volume":"75","author":"K\u00e1lm\u00e1n","year":"2004","journal-title":"Life Sci"},{"issue":"6","key":"10.1016\/j.pharep.2016.09.016_bib0135","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/clinchem\/29.6.1031","article-title":"Pseudocholinesterase\/high-density lipoprotein cholesterol ratio in serum of normal persons and of hyperlipoproteinemics","volume":"29","author":"Jain","year":"1983","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.pharep.2016.09.016_bib0140","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1590\/S1415-47572010005000072","article-title":"Molecular forms of butyrylcholinesterase and obesity","volume":"33","author":"Boberg","year":"2010","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.pharep.2016.09.016_bib0145","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.clinbiochem.2005.04.008","article-title":"Relationship between serum butyrylcholinesterase and the metabolic syndrome","volume":"38","author":"Randell","year":"2005","journal-title":"Clin Biochem"},{"issue":"5","key":"10.1016\/j.pharep.2016.09.016_bib0150","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biopha.2007.10.002","article-title":"Oxidative stress and erythrocyte acetylcholinesterase (AChE) in hypertensive and ischemic patients of both acute and chronic stages","volume":"62","author":"de Carvalho Corr\u00eaa","year":"2008","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharep.2016.09.016_bib0155","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.clinbiochem.2008.01.005","article-title":"Butyrylcholinesterase activity is reduced in haemodialysis patients: is there association with hyperhomocysteinemia and\/or oxidative stress?","volume":"41","author":"Garcia","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/j.pharep.2016.09.016_bib0160","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clinbiochem.2014.08.016","volume":"48","author":"Shahmohamadnejad","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.pharep.2016.09.016_bib0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijdevneu.2005.12.003","article-title":"Folic acid pretreatment prevents the reduction of Na+,K+-ATPase and butyrylcholinesterase activities in rats subjected to acute hyperhomocysteinemia","volume":"24","author":"Matt\u00e9","year":"2006","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.pharep.2016.09.016_bib0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/nbdi.2001.0462","article-title":"Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain","volume":"9","author":"Mesulam","year":"2002","journal-title":"Neurobiol Dis"},{"issue":"9","key":"10.1016\/j.pharep.2016.09.016_bib0175","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s00702-010-0445-0","article-title":"Chronic variable stress induces oxidative stress and decreases butyrylcholinesterase activity in blood of rats","volume":"117","author":"Tagliari","year":"2010","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.pharep.2016.09.016_bib0180","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11011-005-4147-5","article-title":"Reduction of butyrylcholinesterase activity in rat serum subjected to hyperhomocystinemia","volume":"20","author":"Stefanello","year":"2005","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.pharep.2016.09.016_bib0185","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nature04634","article-title":"Reactive oxygen species have a causal role in multiple forms of insulin resistance","volume":"440","author":"Houstis","year":"2006","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.pharep.2016.09.016_bib0190","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3109\/03009734.2012.672345","article-title":"Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatin","volume":"117","author":"Zhong","year":"2012","journal-title":"Ups J Med Sci"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016301979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016301979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:42Z","timestamp":1752611802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.09.016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1734114016301979"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.09.016","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of intensive lipid-lowering therapies on cholinesterase activity in patients with coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Sp. z o.o. on behalf of Institute of Pharmacology, Polish Academy of Sciences.","name":"copyright","label":"Copyright"}]}}